[1] Fukazawa R,Kobayashi J,Ayusawa M,et al.JCS/JSCS 2020 gui-deline on diagnosis and management of cardiovascular sequelae in Kawasaki disease[J]. Circ J,2020,84(8):1348-1407. [2] 刘力. 川崎病休克综合征的早期识别与处理[J]. 中国小儿急救医学,2020,27(5):346-348. Liu L.Early identification and management of Kawasaki disease shock syndrome[J]. Chin Pediatr Emerg Med,2020,27(5):346-348. [3] 徐南娇,胡蕾. 1例免疫检查点抑制剂相关重症心肌炎患者合并心源性休克的护理[J]. 中华护理杂志,2022,57(17):2141-2144. Xu NJ,Hu L.Nursing care of a patient with immune checkpoint inhibitors related cardiogenic shock after acute fulminant myocarditis[J]. Chin J Nurs,2022,57(17):2141-2144. [4] 江莹,黎万汇,陈莹莹,等. 经外周静脉输注血管活性药物风险管理范围的综述[J]. 中华护理杂志,2021,56(7):1105-1110. Jiang Y,Li WH,Chen YY,et al.A scoping review on risk management of peripheral vasoactive medication[J]. Chin J Nurs,2021,56(7):1105-1110. [5] Kohli R,Chaturvedi S.Epidemiology and clinical manifestations of immune thrombocytopenia[J]. Hamostaseologie,2019,39(3):238-249. [6] 赵春娜,杜忠东,高灵灵. 川崎病儿童冠状动脉病变危险因素分析[J]. 中华实用儿科临床杂志,2016,31(9):659-661. Zhao CN,Du ZD,Gao LL.Risk factor analysis of coronary artery lesions in children with Kawasaki disease[J]. Chin J Appl Clin Pediatr,2016,31(9):659-661. [7] 程婷,罗顺清,龙春莉,等. 川崎病并发巨大冠状动脉瘤的护理[J]. 护理实践与研究,2016,13(6):30-32. Cheng T,Luo SQ,Long CL,et al.The nursing of Kawasaki disease with the complication of giant coronary artery aneurysm[J]. Nurs Pract Res,2016,13(6):30-32. [8] 中华医学会儿科学分会心血管学组,中华儿科杂志编辑委员会. 川崎病冠状动脉病变的临床处理建议(2020年修订版)[J]. 中华儿科杂志,2020,58(9):718-724. The Subspecialty Group of Cardiology,the Society of Pediatrics, Chinese Medical Association,Editorial Board of Chinese Journal of Pediatrics. Recommendations for clinical management of Kawasaki disease with coronary artery lesions(2020 revision)[J]. Chin J Pediatr,2020,58(9):718-724. |